quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:00:53·34d
SECFiling
SiNtx Technologies Inc. logo

SEC Form 10-K filed by SiNtx Technologies Inc.

SINT· SiNtx Technologies Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • SINT
    SiNtx Technologies Inc.
    Health Care

Recent analyst ratings

  • Apr 13UpdateH.C. Wainwright$10.00

Related

  • INSIDER9d
    SEC Form 4 filed by Elmore Robert Ryan
  • ANALYST10d
    H.C. Wainwright initiated coverage on SINTX Technologies with a new price target
  • PR31d
    SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution
  • PR35d
    SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant
  • INSIDER36d
    SEC Form 4 filed by SiNtx Technologies Inc.
  • INSIDER44d
    Director Lyons Christopher Michael bought $24,092 worth of shares (8,292 units at $2.91) (SEC Form 4)
  • INSIDER57d
    Director Moyes Jay M bought $2,910 worth of shares (1,000 units at $2.91), increasing direct ownership by 33% to 4,000 units (SEC Form 4)
  • INSIDER63d
    Director Anderson Mark Lewis bought $9,060 worth of shares (3,000 units at $3.02), increasing direct ownership by 20% to 18,000 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022